1 Tables

1.1 Rezultate

Factor

Detalis

cases

controls

Statistics

Group

72 (44.4%)

90 (55.6%)

Sex

F

38 (52.8%)

42 (46.7%)

OR=1.28 [0.69, 2.38], phi=0.06 (p=0.527)

M

34 (47.2%)

48 (53.3%)

Age (years)

μ ±DS

11.93 ±4.27

10.19 ±5.08

MW: p=0.037

Age at onset (years)

μ ±DS

6.84 ±3.97

Body mass index (kg/m²)

μ ±DS

18.96 ±3.37

17.32 ±4.06

MW: p=0.001

Weight (kg)

μ ±DS

45.15 ±17.8

37.00 ±19.8

MW: p=0.004

HbA1c (%)

μ ±DS

8.81 ±1.79

4.81 ±0.451

MW: p<0.001

Insulin intake (IU/kg/day)

μ ±DS

0.949 ±0.271

Injections/day n (%)

4

40 (55.6%)

0

V=NaN (p=1.000)

5

25 (34.7%)

0

insulin pump

7 (9.7%)

0

Neuropathy n (%)

24 (33.3%)

0

OR=91.43 [5.44, 1 536.40], phi=0.47 (p<0.001)

Nephropathy n (%)

6 (8.6%)

0

OR=18.24 [1.01, 329.56], phi=0.22 (p=0.006)

Retinopathy, n (%)

2 (2.8%)

0

OR=6.42 [0.30, 135.84], phi=0.12 (p=0.196)

Other complications*

59 (81.9%)

0

OR=797.74 [46.54, Inf], phi=0.85 (p<0.001)

Systolic blood pressure (mmHg)

μ ±DS

100.21 ±11.9

101.50 ±12.9

MW: p=0.575

Diastolic blood pressure (mmHg)

μ ±DS

54.65 ±10.7

56.83 ±9.32

MW: p=0.219

Adiponectin (μg/L)

μ ±DS

14.07 ±4.69

TNF-alfa (pg/mL)

μ ±DS

11.09 ±4.21

Alfa 1AT

μ ±DS

133.50 ±18.2

155.07 ±28.3

MW: p=0.002

Cholesterol (mg/dL)

μ ±DS

169.57 ±41.0

153.19 ±22.3

MW: p=0.008

Triglycerides (mg/dL)

μ ±DS

85.32 ±48.5

72.43 ±29.0

MW: p=0.132

HDL (mg/dL)

μ ±DS

54.47 ±11.3

53.40 ±9.76

MW: p=0.693

μ ±DS = Mean (standard deviation); M (min:max) = Median (min:max); MW = Mann-WhitneyTest; OR/RR = odds-ratio / risc-ratio [95% CI] and p value from Fisher test); V = Cramer V (p value from Chi² test);

2 Referințe

  1. R Core Team (2019). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.